Implementing Precision Medicine Approaches to Guide Anti-platelet Selection
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04090281
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT04090281
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT04090281. Allocation not applicable; no masking; primary purpose treatment. Start 2020-03-13 (actual); primary completion 2023-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Implementing Precision Medicine Approaches to Guide Anti-platelet Selection
- Condition
- Acute Coronary Syndrome (ACS)
- Condition
- STEMI - ST Elevation Myocardial Infarction (MI)
- Condition
- NSTEMI - Non-ST Segment Elevation MI
- Condition
- Unstable Angina (UA)
- Intervention (Genetic)
- CYP2C19 genotyping
- Lead sponsor
- University of Southern California
Record details
- Record id
cardio:ct-nct04090281- Content hash
a185359d24405de9052f35af294796cd321a52cb109582bc54588ade18a53ee3